Current Lab Members

Christopher Counter, Ph.D.

Principle Investigator

Professor of Pharmacology & Cancer Biology, Radiation Oncology

Hema Adhikari, Ph.D.

Postdoctoral fellow exploring how oncogenic RAS proteins signal through interrogating their interactomes using proximity-labeling technologies coupled with CRISPR/Cas9 loss-of-function screens.

  • Adhikari & Counter, Nat Commun 2021
  • Adhikari & Counter, Methods Mol Biol, accepted.
  • Adhikari & Counter, Nat Commun 2018

 

Özgün Erdoǧan, Ph.D.

Postdoctoral fellow exploring how the relationship between oncoprotein levels and mutation types affect tumor initiation in different tissues using genetically engineered mouse models of human cancers.

 

Seth Zimmerman, Ph.D.

Postdoctoral fellow exploring how phosphatidylinositol metabolism influences tumorigenesis by employing targeted in vivo CRISPR/Cas9 loss-of-function screens. He is also studying how PAX3-FOXO1 promotes the childhood solid cancer  rhabdomyosarcoma by mapping the interactome of this fusion oncoprotein.

Wenceslaus Githiiyi

Technician aiding postdoctoral fellow Dr. Ozgun Erdogan with studies into the relationship between oncoprotein levels and mutation type of RAS genes.

Kevin Kavilaveettil

Undergraduate student undertaking bioinformatic analysis of protein interactomes.